Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin VIAject vs Regular Human Insulin and Lispro in Type 2 Diabetes
NCT00849576Phase 3Completed
- Sponsor
- Biodel Inc.
- Start
- Apr 2008
- Primary completion
- Aug 2008
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of VIAject in type 2 diabetes mellitus (T2DM), sponsored by Biodel Inc.. Started Apr 2008; status: completed.
02
Drugs
VIAject
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00849576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00849576.